Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Article by Dr. Robert G. Schwartz of Piedmont Physical Medicine & Rehabilitation Looks at Benefits of Stem Cell Therapy for Knees
  • USA - English


News provided by

Piedmont Physical Medicine & Rehabilitation

Jun 02, 2015, 01:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Robert G. Schwartz specializes in Physical, Vascular and Regenerative Medicine, and offers non-surgical specialty care for complex, chronic pain.
Dr. Robert G. Schwartz specializes in Physical, Vascular and Regenerative Medicine, and offers non-surgical specialty care for complex, chronic pain.

Greenville, SC (PRWEB) June 02, 2015 -- Dr. Robert G. Schwartz, the principal of Greenville, SC-based Piedmont Physical Medicine & Rehabilitation, P.A., has published a new article that looks at the benefits of stem cell therapy for knees, and highlights it as a viable and in many cases preferred alternative to arthroscopy or knee joint replacement.

We are impressed and inspired by the outcomes we are seeing for stem cell therapy for osteoarthritis in knees, as well as in hips, ankles, back, shoulders and spine.

Post this

Dr. Schwartz, who is an internationally-renowned practitioner of Neuromusculoskeletal, Vascular and Regenerative Medicine, writes that both autologus and placental derived stem cells can produce outstanding results, as evidenced by the fact that 74% of his patients reported more than 80% of lasting relief*.

Dr. Schwartz also notes the key advantages and drawbacks to using autologus or placental derived stem cells:

Autologus stem cells, which derive from a patient’s own blood or marrow, typically lead to a “Eureka” day within 21 days of grafting, and seem to have a relatively faster onset of action compared to placental derived stem cells. As a result, pain relief occurs more rapidly in the majority of cases. Drawbacks include the need to harvest stem cells, and the need for a platelet rich plasma (PRP) booster one month after treatment to ensure full benefit and impact.

Placental stems cells, which are found in the placenta and collected after the blood from the umbilical cord is drawn, seem to keep working longer relative to autologus stem cells. Furthermore, the grafting procedure is simple, and an PRP booster is not required. However, they appear to work slower, which can result in the delayed onset of peak pain relief.

With respect to stem cell therapy for other conditions, Dr. Schwartz’s also highlights considerably positive success indicators, including:

• For chronic low back pain, 67% of patients reported at least 80% of lasting relief, and 72% reported at least 50% of lasting relief.
• For CRPS/RSD, Peripheral Neuropathy, and Peripheral Vascular Disease (PAD), 43% of patients reported at least 90% of lasting relief, and 86% reported at least 50% of lasting relief.
• For ankles and shoulders, 50% of patients reported at least 50% of lasting relief.

“We are impressed and inspired by the outcomes we are seeing for stem cell therapy for osteoarthritis in knees, as well as in hips, ankles, back, shoulders and spine,” commented Dr. Schwartz, who has been practicing medicine for 31 years, and who also serves as the Medical Director of Physical Medicine at Bons Secours Hospital in Greenville, SC. “It is not uncommon for patients to report that their walking endurance has increased more than 700%, and that the so-called `bad’ joint or limb that had been troubling them for years or decades actually feels stronger than the `good’ one!”

The full text of Dr. Schwartz’s latest article entitled “Stem Cell for Knees” is available at http://piedmontpmr.com/stem-cell-for-knees.    

For additional information, article reprint/republication requests, or media inquiries, contact Sheri Schwartz, Practice Administrator, at (864) 235-1834 or ppmrpublic(at)safe-mail(dot)net.

About Piedmont Physical Medicine & Rehabilitation, P.A.

Robert G. Schwartz, MD has independently owned and operated Piedmont Physical Medicine and Rehabilitation, P.A. in Greenville, South Carolina, USA, since 1984. He specializes in Physical, Vascular and Regenerative Medicine, and offers non-surgical specialty care for complex, chronic pain. Learn more at http://piedmontpmr.com

  • “Lasting relief” is defined by Dr. Schwartz as relief persisting more than six months after treatment. This definition is applied in order to generate more robust and credible results by filtering out any cases where a patient may report experiencing initial or short-term relief, yet later report that it has somewhat or significantly diminished.

Sheri Schwartz, Practice Administrator, Piedmont Physical Medicine & Rehabilitation, http://piedmontpmr.com, +1 (864) 235-1834, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.